Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LOXO | CRNX | STVN | ||
| Company | Loxo Oncology CS | Crinetics Pharmaceuticals Inc | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 234.80 | 83.75 | 19.55 | ||
| High | 234.80 | 83.80 | 19.80 | ||
| Low | 234.80 | 83.68 | 19.12 | ||
| Latest | 234.80 | 83.73 | 19.68 | ||
| Change | +0.14 | +0.08 | +0.28 | ||
| % Change | +0.06% | +0.10% | +1.44% | ||
| Volume | 800 | 2,344,322 | 336,366 | ||
| 20-Day Average Volume | 642,620 | 8,659,681 | 285,343 | ||
| Previous Close | 234.66 | 83.65 | 19.40 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 234.28 | 70.31 | 19.13 | ||
| 20-Day Raw Stochastic | 92.26% | 99.45% | 80.59% | ||
| 20-Day Relative Strength | 75.87 | 88.62 | 57.93 | ||
| Weighted Alpha | +47.60 | +50.08 | -16.81 | ||
| Today's Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Last Month's Opinion | 56% Buy | 88% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.16% since 02/08/19 | -0.16% since 07/17/26 | +2.66% since 07/17/26 | ||
| Low | 234.43 on 02/11/19 | 83.64 on 07/23/26 | 18.79 on 07/20/26 | ||
| High | 234.93 on 02/13/19 | 84.00 on 07/21/26 | 19.88 on 07/23/26 | ||
| 1-Month | |||||
| %Chg | +0.48% since 01/15/19 | +131.43% since 06/24/26 | +14.15% since 06/24/26 | ||
| Low | 233.14 on 01/16/19 | 34.71 on 06/25/26 | 17.21 on 06/25/26 | ||
| High | 234.93 on 02/13/19 | 84.00 on 07/16/26 | 20.27 on 07/10/26 | ||
| 3-Month | |||||
| %Chg | +54.95% since 11/15/18 | +118.45% since 04/24/26 | +21.63% since 04/24/26 | ||
| Low | 125.00 on 12/24/18 | 32.30 on 06/02/26 | 15.78 on 04/28/26 | ||
| High | 234.93 on 02/13/19 | 84.00 on 07/16/26 | 20.27 on 07/10/26 | ||
| 6-Month | |||||
| %Chg | +49.33% since 08/15/18 | +57.45% since 01/23/26 | +13.95% since 01/23/26 | ||
| Low | 125.00 on 12/24/18 | 32.30 on 06/02/26 | 12.89 on 03/27/26 | ||
| High | 234.93 on 02/13/19 | 84.00 on 07/16/26 | 20.27 on 07/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,182,943 | 8,820,056 | 5,875,154 | ||
| Shares Outstanding, K | 30,615 | 105,440 | 302,843 | ||
| Annual Sales | 21,300,000 | 7,700,000 | 1,342,160,000 | ||
| Annual Net Income | -148,880,000 | -465,320,000 | 158,210,000 | ||
| Last Quarter Sales | 42,470,000 | 10,730,000 | 320,190,000 | ||
| Last Quarter Net Income | -27,060,000 | -127,850,000 | 32,810,000 | ||
| 60-Month Beta | 2.51 | 0.23 | 0.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.89 on 11/08/18 | -1.23 on 05/07/26 | 0.13 on 05/07/26 | ||
| Earnings Date | 03/07/19 | 08/04/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 31.24 | ||